Affibody
About:
Affibody is a Swedish biotech company focused on developing products for therapy, diagnostic imaging, and other applications.
Website: http://www.affibody.se
Top Investors: European Investment Bank, KTH Holding, Kaupthing Bank
Description:
Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. Affibody® molecules, which are small, robust and easily produced, can be designed to bind specifically to a large number of target proteins. They have a broad range of applications including protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostics, including molecular imaging, and targeted therapeutics.
$49.9M
$1M to $10M
Stockholm, Stockholms Lan, Sweden
1998-01-01
reception(AT)affibody.com
Mathias Uhlén
101-250
2022-12-23
Private
© 2025 bioDAO.ai